Demineralized Cortical Bone Powder 125 – 850 μm | Quantity |
---|---|
Demineralized Cortical Bone Powder 125 – 850 μm | 0.5 cc |
Demineralized Cortical Bone Powder 125 – 850 μm | 1 cc |
Demineralized Cortical Bone Powder 125 – 850 μm | 2 cc |
Cortical Cancellous Bone Powder 125 – 850 μm | Quantity |
---|---|
Cortical Cancellous Bone Powder 125 – 850 μm | 0.5 cc |
Cortical Cancellous Bone Powder 125 – 850 μm | 1 cc |
Cortical Cancellous Bone Powder 125 – 850 μm | 2 cc |
Cancellous Bone Powder 125 – 850 μm | Quantity |
---|---|
Cancellous Bone Powder 125 – 850 μm | 0.5 cc |
Cancellous Bone Powder 125 – 850 μm | 1 cc |
Cancellous Bone Powder 125 – 850 μm | 2 cc |
Advanced tissue processing and quality systems ensure that each and every allograft meets safety and regulatory requirements. These quality standards are written to meet regulations established by the FDA, AATB (American Association of Tissue Banks), Health Canada, and other guidelines as appropriate.
As with all allogeneic materials, it is not possible to provide an absolute guarantee that no infectious disease will be transmitted. However, this risk is greatly reduced by using processing treatments shown to be capable of reducing this risk as well as the use of strict donor screening criteria, laboratory testing, aseptic processing and gamma irradiation of the final product.
See Instructions for Use
OSSIX® Graft particulate allograft products consist of cortical bone matrix and may be used in a variety of reconstructive, periodontal, and oral maxillofacial procedures. OSSIX® Graft contains Human Cellular and Tissue Based Product (HCT/P).
Please see accompanying Instructions for Use Click here for Instructions for Use.